Medicross Laboratories Private Limited, a active private limited company, was established on 15 July 1996 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U51397MH1996PTC101063. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.70 Cr and a paid-up capital of ₹4.99 M.
It upholds a compliant status. Its leadership includes Ram Pratap Singh (Director), Sunita Singh (Director). Past directors included Askand Krishna, Abhishek Singh, Utkarsh Singh. It holds ₹9.69 Cr open charges and ₹3.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1003 Cluster 4, Bldg. No. L-11, Sno. 150Pt, 151 Pt Opp Surya Shopping Centre, Mira Road (Ea, St), Thane, Mumbai, Maharashtra, 401107.
U51397MH1996PTC101063
101063
15 July 1996
₹2.70 Cr
₹4.99 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medicross Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ram Pratap Singh | Director | 15 Jul 1996 | Current |
| Sunita Singh | Director | 28 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 May 2025 | Past |
| Pramod Abcsdd | Director | 04 Dec 2024 | Past |
| Pramod Abcsdd | Director | 14 Sep 2018 | Past |
| Pramod Abcsdd | Director | 30 Dec 2024 | Past |
| Pramod Abcsdd | Director | 28 Dec 2024 | Past |
| Pramod Abcsdd | Director | 16 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medicross Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45434.5% increase. The company also saw a substantial improvement in profitability, with a 18981.2% increase in profit. The company's net worth Soared by an impressive increase of 10155.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medicross Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹96,858,000.00
₹39,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2023 | Axis Bank Limited | ₹4.49 Cr | Open |
| 24 Jul 2023 | Axis Bank Limited | ₹5.19 Cr | Open |
| 29 Sep 2021 | Bank Of India | ₹3.90 Cr | Satisfied |
| 23 Oct 2000 | Oriental Bank Of Commerce | ₹0.45 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medicross Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medicross Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicross Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sunita Singh was appointed as a Director was appointed as a Director on 28 Apr 2025 & has been associated with this company since 7 months 21 days . was documented.
The activity A charge registered on 29 Sep 2021 via Charge ID 100492730 with Bank Of India was fully satisfied on 20 Jan 2025. was completed.
The activity Medicross Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Axis Bank Limited of Rs. 5.19 Cr registered on 24 Jul 2023 with Charge ID 100812582 was modified on 15 Jul 2024. was completed.
Progress on Medicross Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 4.49 Cr with Charge ID 100781281 was registered on 13 Sep 2023. was documented.
The CIN of Medicross Laboratories Private Limited is U51397MH1996PTC101063.
Medicross Laboratories Private Limited is headquartered at 1003 Cluster 4, Bldg. No. L-11, Sno. 150Pt, 151 Pt Opp Surya Shopping Centre, Mira Road (Ea, St), Thane, Mumbai, Maharashtra, 401107.
Medicross Laboratories Private Limited was incorporated on 15 July 1996.
The current directors of Medicross Laboratories Private Limited are
The primary industry of Medicross Laboratories Private Limited is Manufacturing.
Medicross Laboratories Private Limited is unlisted.
The authorized capital of Medicross Laboratories Private Limited is ₹2.70 Cr, and the paid-up capital is ₹4.99 M.
The compliance status of Medicross Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX